EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours - Aapro, MS; Cameron, DA; Pettengell, R (Eur J Cancer, 2006)